MedPath

Comparison of the effects of Cetirizine and Desloratadine on the symptoms of chronic spontaneous urticarial

Phase 2
Recruiting
Conditions
Chronic urticaria.
Urticaria
Registration Number
IRCT20211219053449N1
Lead Sponsor
Mashhad University of Medical Sciences
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
180
Inclusion Criteria

The purpose of the study will be explained to all patients and written informed consent will be obtained.
CSU patients with a history of chronic spontaneous urticaria for at least six weeks during the last three months
who did not respond to standard doses of second-generation antihistamines
the illness was not controlled according to the disease questionnaire.

Exclusion Criteria

Pregnancy
Drug-induced urticaria
Vasculitis urticaria
Hereditary angioedema
Colitis urticaria
Physical urticaria
cold urticaria

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
CT questionnaire score: assessment of pruritus and urticaria symptoms. Timepoint: before and after 14 days of taking the drug. Method of measurement: UCT questionnaire.;CU-QoL questionnaire: assessment of quality of life. Timepoint: At the beginning of the study and 2 weeks after taking the drug. Method of measurement: Chronic Urticaria-Quality of Life Questionnaire (CU-QoL).
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath